检索结果 - Ming‐Hsin Yeh
- Showing 1 - 4 results of 4
-
1
-
2
<scp>MEK</scp> inhibitors induce Akt activation and drug resistance by suppressing negative feedback <scp>ERK</scp> ‐mediated <scp>HER</scp> 2 phosphorylation at Thr701 由 Chia‐Hung Chen, Te‐Chun Hsia, Ming‐Hsin Yeh, T.-H. Chen, Yun‐Ju Chen, Jung‐Tsu Chen, Ya‐Ling Wei, Chih‐Yen Tu, Wei‐Chien Huang
出版 2017Artigo -
3
Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors 由 Yun‐Ju Chen, Ming‐Hsin Yeh, Meng-Chieh Yu, Ya-Ling Wei, Wen-Shu Chen, Jhen-Yu Chen, Chih-Yu Shih, Chih‐Yen Tu, Chia‐Hung Chen, Te‐Chun Hsia, Pei‐Hsuan Chien, Shu-Hui Liu, Yung‐Luen Yu, Wei‐Chien Huang
出版 2013Artigo -
4
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer 由 Po‐Han Lin, Wen‐Hung Kuo, Ai-Chu Huang, Yen‐Shen Lu, Ching‐Hung Lin, Sung‐Hsin Kuo, Ming-Yang Wang, Chunyu Liu, Fiona Tsui-Fen Cheng, Ming‐Hsin Yeh, Huei-Ying Li, Yu-Hsuan Yang, Yu-Hua Hsu, Sheng-Chih Fan, Long‐Yuan Li, Sung‐Liang Yu, King‐Jen Chang, Pei‐Lung Chen, Yen‐Hsuan Ni, Chiun‐Sheng Huang
出版 2016Artigo
相关主题
Biology
Breast cancer
Cancer
Cancer research
Internal medicine
Medicine
Oncology
Gene
Genetics
Signal transduction
Bioinformatics
Cell biology
Chemistry
Extracellular
Extracellular matrix
Inflammation
Kinase
Lapatinib
MAPK/ERK pathway
MEK inhibitor
Multiple myeloma
NF-κB
PI3K/AKT/mTOR pathway
Phosphorylation
Proteasome inhibitor
Protein kinase B
Receptor
Surgical oncology
Trastuzumab
Triple-negative breast cancer